Exchange: NYSE Sector: Healthcare Industry: Medical Devices
2.15% $63.06
America/New_York / 9 mai 2024 @ 13:49
FUNDAMENTALS | |
---|---|
MarketCap: | 8 515.89 mill |
EPS: | 0.540 |
P/E: | 116.77 |
Earnings Date: | Aug 01, 2024 |
SharesOutstanding: | 135.05 mill |
Avg Daily Volume: | 1.149 mill |
RATING 2024-05-09 |
---|
B |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Sell | |
Return On Asset: | Neutral | |
DE: | Neutral | |
P/E: | Strong Sell | |
Price To Book: | Neutral |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
7.57x |
Company: PE 116.77 | sector: PE 15.43 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE 116.77 | industry: PE -41.13 |
DISCOUNTED CASH FLOW VALUE |
---|
$77.14 (22.34%) $14.08 |
Date: 2024-05-09 |
Expected Trading Range (DAY) |
---|
$ 61.65 - 64.30 ( +/- 2.10%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-15 | Norwalk Leslie V | Sell | 10 590 | Class A Common Stock |
2024-03-01 | Huller Kelly | Buy | 7 500 | Class A Common Stock |
2024-03-01 | Huller Kelly | Sell | 4 385 | Class A Common Stock |
2024-03-01 | Huller Kelly | Sell | 3 115 | Class A Common Stock |
2024-03-01 | Huller Kelly | Sell | 7 500 | Stock Option (Right to Buy Class A Common Stock) |
INSIDER POWER |
---|
35.55 |
Last 97 transactions |
Buy: 1 356 874 | Sell: 676 934 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $63.06 (2.15% ) |
Volume | 0.903 mill |
Avg. Vol. | 1.149 mill |
% of Avg. Vol | 78.59 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.